ArticleLeukemia2024

Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials.

Georg Lenz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.